Fingerprint
Dive into the research topics of 'Is dystrophin immunogenicity a barrier to advancing gene therapy for Duchenne muscular dystrophy?'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Is dystrophin immunogenicity a barrier to advancing gene therapy for Duchenne muscular dystrophy?
Dariusz C. Górecki, Pawel Kalinski, Joanna Pomeroy
Research output: Contribution to journal › Article › peer-review
1
Downloads
(Pure)